jeudi 23 janvier 2020

Onco Actu du 23 janvier 2020


3.1.1 PRÉVENTION - TABAC - E-CIGS



Congress calls Juul, four other vape companies to testify about youth vaping [STAT]











WHO warning on vaping draws harsh response from U.K. researchers [Science]










Is vaping safe? What the latest research says about the cigarette substitute [The Telegraph]











4.3 DÉP., DIAG. & PRONO. - INDUSTRIELS



Myriad Submits sPMA for myChoice® CDx with Zejula® in First-Line Platinum Responsive Advanced Ovarian Cancer [Myriad]











4.7 DÉP., DIAG. & PRONO. - COL DE L'UTÉRUS



Cervical cancer progress falters as screening uptake hits record lows [Cancer Research UK]










5.1 TRAITEMENTS - PRÉ-CLINIQUE



Antiviral treatments inspire Stanford researchers to develop a new kind of cancer drug [Stanford]











5.12.11 IMMUNOTHÉRAPIES - PRÉ-CLINIQUE



Immunotherapy Screening Using Immune-Enhanced Organoids [GEN]











5.12.13 IMMUNOTHÉRAPIES - BIOMARQUEURS



B Cell Gene Expression Profiling May Enable Cancer Immunotherapy CDx Test [Genome Web]











5.12.3 IMMUNOTHÉRAPIES-COMBINAISONS



Targovax plans checkpoint combo trial after posting early data on oncolytic virus [Fierce Biotech]











5.12.5.1 IMMUNOTHÉRAPIES - BIOTECH



Korean VCs pile into PDC*line to bankroll NSCLC vaccine trial [Fierce Biotech]











PDC*line Pharma Raises €20 million ($22.2M) In Series B Financing Round [PDC*line Pharma]











French-Belgian biotech banks €20M to break ground in blood-splattered field of therapeutic cancer vaccines [EndPoints]











5.17 TRAITEMENTS - RADIOTHÉRAPIE



Increased radiation intensity found to be safe for the treatment of prostate cancer [CA: A Cancer Journal for Clinicians]










5.2.6 PHARMA - BIOTECH



Chi-Med stops pivotal pancreatic cancer trial upon early success [Fierce Biotech]











5.3 TRAITEMENTS - FDA, EMA,...



Court of Justice upholds EMA’s approach to transparency [EMA]











5.3.4 TRAITEMENTS - AMM (FDA, EMA,...)



Roche wins approval for cancer drug Kadcyla in fast-growing China market [Reuters]











5.4.1 TRAITEMENTS - ECONOMIE - NICE



NICE shuts out AstraZeneca's Tagrisso—and dings J&J's Stelara, too [Fierce Pharma]











NICE stays sour on AstraZeneca's Tagrisso [EndPoints]











6. LUTTE CONTRE LES CANCERS



Supporting adult carers [NICE]










Care matters – Working together to get support right for adult carers [NICE]











6.3 ASSOCIATIONS/FONDATIONS



The prevalence of industry funding of patient groups [BMJ]










6.6 PUBLICATIONS, POLITIQUES SCIENTIFIQUES



Has reproducibility improved? Introducing the Transparency and Rigor Index [Retraction Watch]










Software searches out reproducibility issues in scientific papers [Nature]











6.7.3 DMP



Epic’s CEO is urging hospital customers to oppose rules that would make it easier to share medical info [CNBC]